Alessandro Lucchesi

19PUBLICATIONS
57CO-AUTHORS
Immunogenetics (incl. genetic immunology)Haematological tumoursGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 25, 2026
Clinical Outcomes of Ruxolitinib Treatment in Patients With IPSS Intermediate-1-Risk Myelofibrosis: Interim Analysis From an Italian, Prospective Study (ROMEI).

Paola Guglielmelli, Massimo Breccia, Francesco Mendicino

|Jul 02, 2024
Targeting exhausted cytotoxic T cells through CTLA-4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts.

Lara Tavernari, Sebastiano Rontauroli, Ruggiero Norfo

|Apr 15, 2024
Sailing in deceptive calm: Navigating the undercurrents of essential thrombocythaemia.

Yoshinori Hashimoto, Alessandro Lucchesi

|Jan 11, 2024
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment.

Maria Teresa Bochicchio, Giovanni Marconi, Carmen Baldazzi

|Nov 25, 2023
Germline CSF3R Variant in Chronic Myelomonocytic Leukemia: Linking Genetic Predisposition to Uncommon Hemorrhagic Symptoms.

Maria Teresa Bochicchio, Giorgia Micucci, Silvia Asioli

|Aug 08, 2023
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis.

Stephen T Oh, Ruben A Mesa, Claire N Harrison

Pageof 4

Frequent Collaborators

5 joint publications

Maria Teresa Bochicchio

5 joint publications

Giulio Giordano

3 joint publications

Paola Di Carlo

2 joint publications

Roberta Napolitano